Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
9.19
-0.10 (-1.08%)
Jan 28, 2026, 1:09 PM EST - Market open

Grifols Revenue

Grifols had revenue of 1.89B EUR in the quarter ending June 30, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 7.45B, up 9.32% year-over-year. In the year 2024, Grifols had annual revenue of 7.21B with 9.41% growth.

Revenue (ttm)
7.45B EUR
Revenue Growth
+9.32%
P/S Ratio
0.90
Revenue / Employee
313,675 EUR
Employees
23,737
Market Cap
7.92B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.21B620.41M9.41%
Dec 31, 20236.59B528.01M8.71%
Dec 31, 20226.06B1.13B22.92%
Dec 31, 20214.93B-406.92M-7.62%
Dec 31, 20205.34B241.35M4.73%
Dec 31, 20195.10B611.97M13.64%
Dec 31, 20184.49B168.65M3.91%
Dec 31, 20174.32B268.24M6.62%
Dec 31, 20164.05B115.27M2.93%
Dec 31, 20153.93B579.18M17.26%
Dec 31, 20143.36B613.65M22.38%
Dec 31, 20132.74B120.79M4.61%
Dec 31, 20122.62B825.33M45.96%
Dec 31, 20111.80B804.88M81.24%
Dec 31, 2010990.73M77.54M8.49%
Dec 31, 2009913.19M98.88M12.14%
Dec 31, 2008814.31M111.02M15.79%
Dec 31, 2007703.29M54.87M8.46%
Dec 31, 2006648.42M124.69M23.81%
Dec 31, 2005523.73M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Merck & Co.64.24B
Pfizer62.79B
Sanofi53.89B
Novo Nordisk49.58B
Bristol-Myers Squibb Company48.03B
GSK plc43.24B
Amgen35.97B
Gilead Sciences29.09B
Revenue Rankings